Gregory Chin
18Patents
6h-index
51Co-inventors
65Inventor score
Filing activity: Mar 27, 2014 → Jun 14, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9670205B2 | Toll like receptor modulator compounds | Chemistry; Metallurgy | 54 | Active |
| US10640499B2 | Toll like receptor modulator compounds | Human Necessities | 28 | Active |
| US10370342B2 | Toll like receptor modulator compounds | Chemistry; Metallurgy | 26 | Active |
| US9458145B2 | Benzimidazole derivatives as bromodomain inhibitors | Chemistry; Metallurgy | 11 | Active |
| US9255089B2 | Benzimidazolone derivatives as bromodomain inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10285990B2 | Toll like receptor modulator compounds | Chemistry; Metallurgy | 6 | Active |
| US11124487B2 | Toll like receptor modulator compounds | Chemistry; Metallurgy | 5 | Active |
| US11827609B2 | Toll like receptor modulator compounds | Chemistry; Metallurgy | 2 | Active |
| US12091420B2 | SARS-COV2 main protease inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12377100B2 | Toll like receptor modulator compounds | Chemistry; Metallurgy | 0 | Active |
| US12264173B2 | Antiviral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US11767337B2 | Antiviral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US12030903B2 | Antiviral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US10017501B2 | Benzimidazole derivatives as bromodomain inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12410183B2 | Sars-cov2 main protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11179397B2 | Imidazopyrimidine derivatives | Chemistry; Metallurgy | 0 | Active |
| US12110294B2 | CD73 compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US11919869B2 | CD73 compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.